Open AccessRegenerative Injectable Therapies: Current Evidence
Author(s) -
William H. West,
Anthony I. Beutler,
Christopher R Gordon
Publication year - 2020
Publication title -
current sports medicine reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.424
H-Index - 51
eISSN - 1537-8918
pISSN - 1537-890X
DOI - 10.1249/jsr.0000000000000751
Subject(s) - medicine , regenerative medicine , prolotherapy , platelet rich plasma , intensive care medicine , regeneration (biology) , sports medicine , stem cell , bioinformatics , physical therapy , pathology , alternative medicine , platelet , genetics , biology , microbiology and biotechnology
Regenerative medicine is a growing field of musculoskeletal treatments that focuses on amplifying the body's natural healing properties to improve function and pain after injury. Regenerative treatments are applied locally at the site of injury and work though different mechanisms, some of which are unexplained at this time. Current evidence demonstrates benefit for certain regenerative treatments, but further standardization of treatments and additional studies are required to provide additional data to support specific regenerative treatments. This review seeks to explore the evidence and discuss appropriate use of the most common regenerative treatments including platelet-rich plasma, prolotherapy, autologous mesenchymal stem cells, human-derived allograft products, and saline.